Publicaciones en colaboración con investigadores/as de German Cancer Research Center (77)

2023

  1. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

2022

  1. Autophagy in Hematological Malignancies

    Cancers, Vol. 14, Núm. 20

  2. Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study

    Blood Cancer Journal

2021

  1. Polymorphisms within the TNFSF4 and mapkapk2 loci influence the risk of developing invasive aspergillosis: A two-stage case control study in the context of the aspbiomics consortium

    Journal of Fungi, Vol. 7, Núm. 1, pp. 1-17

  2. Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study

    The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204

2020

  1. Host immune genetic variations influence the risk of developing acute myeloid leukaemia: results from the NuCLEAR consortium

    Blood Cancer Journal, Vol. 10, Núm. 7

  2. Reply to: Comment to: Helicobacter pylori seroprevalence in Spain: influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention

2019

  1. Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

  2. Association of menopausal characteristics and risk of coronary heart disease: A pan-European case-cohort analysis

    International Journal of Epidemiology, Vol. 48, Núm. 4, pp. 1275-1285

  3. Association of plasma Vitamin D metabolites with incident type 2 diabetes: EPIC-InterAct case-cohort study

    Journal of Clinical Endocrinology and Metabolism, Vol. 104, Núm. 4, pp. 1293-1303

  4. Coffee and tea drinking in relation to the risk of differentiated thyroid carcinoma: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    European Journal of Nutrition, Vol. 58, Núm. 8, pp. 3303-3312

  5. Correction: Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients (The Pharmacogenomics Journal, (2019), 19, 1, (83-96), 10.1038/s41397-018-0057-x)

    Pharmacogenomics Journal

  6. Estimated Substitution of Tea or Coffee for Sugar-Sweetened Beverages Was Associated with Lower Type 2 Diabetes Incidence in Case-Cohort Analysis across 8 European Countries in the EPIC-InterAct Study

    Journal of Nutrition, Vol. 149, Núm. 11, pp. 1985-1993

  7. Helicobacter pylori seroprevalence in Spain: Influence of adult and childhood sociodemographic factors

    European Journal of Cancer Prevention, Vol. 28, Núm. 4, pp. 294-303

  8. Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients

    Pharmacogenomics Journal, Vol. 19, Núm. 1, pp. 83-96

2018

  1. Circulating fetuin - A and risk of type 2 diabetes: A mendelian randomization analysis

    Diabetes, Vol. 67, Núm. 6, pp. 1200-1205

  2. Consumption of fruits, vegetables and fruit juices and differentiated thyroid carcinoma risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) study

    International Journal of Cancer, Vol. 142, Núm. 3, pp. 449-459

  3. Nutritional quality of food as represented by the FSAm-NPS nutrient profiling system underlying the Nutri-Score label and cancer risk in Europe: Results from the EPIC prospective cohort study

    PLoS Medicine, Vol. 15, Núm. 9

  4. Pre-diagnostic circulating insulin-like growth factor-I and bladder cancer risk in the European Prospective Investigation into Cancer and Nutrition

    International Journal of Cancer, Vol. 143, Núm. 10, pp. 2351-2358

  5. Prediction of acute myeloid leukaemia risk in healthy individuals

    Nature, Vol. 559, Núm. 7714, pp. 400-404